AGP Executive Report
Last update: 7 hours agoTexas Hemp Crackdown: The Texas Supreme Court says hemp-derived THC products like delta-8/delta-10/THCP are controlled substances, raising the stakes for shoppers and sellers and potentially turning possession into felony trouble. Ireland Vape Safety Alarm: Ireland’s HSE says high-risk synthetic cannabinoids were found in vapes, vape juice, and edibles sold in shops and online, with harms including psychosis and severe intoxication—prompting calls for stronger rules and better labeling. South Dakota Home-Grow Surge: South Dakota Health officials report licensed home medical cannabis growers jumped from 61 (FY2022) to 715 (FY2026), while regulators worry about weak oversight and sketchy grow-room documentation. Oregon Psilocybin Results: A large real-world Oregon study in JAMA Network Open reports state-regulated psilocybin services improved anxiety, depression, and PTSD for many participants, with safety and symptom tracking in licensed settings. Cannabis & Health Research: Multiple reports highlight cannabis’s mixed health picture—ranging from heart-risk concerns to studies linking cannabis use patterns with mental health outcomes—while Stroke Burden: an African Stroke Organisation leader warns up to half of stroke survivors may face cognitive impairment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Cannabis-Based Oil Fails to Improve Pain or Nonmotor Symptoms in Parkinson Disease Study]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27693930-935721615-b237f6d5ccd92206f92128a11b3721457ba9ddb7-1950x1021-200x105.png)
![<![CDATA[Cannabis-Based Oil Fails to Improve Pain or Nonmotor Symptoms in Parkinson Disease Study]]>](/images/news-fallback.svg)
